Japanese’s pharma company Astellas Pharma https://www.astellas.com/announced its “Strategic Plan 2018”, comprehensive of the restructuring of operations in Japan and of the introduction of an early retirement incentive program. The goal is to optimise the organisational capabilities of the company, according to which all operations will be restructured, including R&D and Sales & Marketing, and its group companies in Japan.